Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)
NCT04946929 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2021-07-01
Summary
Hepatic artery thrombosis (HAT) represents a major cause of graft loss and mortality after Pediatric liver transplantation. Ticagrelor (a new reversible inhibitor of P2Y12 receptor with faster onset of action and greater platelet inhibition) was used to treat patients with pediatric post-transplant hepatic artery thrombosis (HAT) compared to low molecular weight heparin.
Conditions
- Hepatic Artery Thrombosis
- Liver Transplant; Complications
- Pediatric Disease
Interventions
- DRUG
-
Ticagrelor Oral Tablet [Brilinta]
Ticagrelor, 2-3mg/kg, 12h, p.o.
- DRUG
-
Low molecular weight heparin
half amount low molecular weight heparin
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
Hao Feng, MD. Ph.D · Dept. Liver Surgery, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine
-
Chuan Shen, MD · Dept. Liver Surgery, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine
-
Xiaosong Chen, MD · Dept. Liver Surgery, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine
-
Qiang XIA, MD. Ph.D · Dept. Liver Surgery, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Months
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-31
- Primary Completion
- 2022-12-31
- Completion
- 2023-03-31
Countries
- China
Study Locations
More Related Trials
-
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
NCT01752049 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement
NCT02540226 ·Status: COMPLETED ·Phase: PHASE4
-
Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty(TKA)
NCT07127042 ·Status: RECRUITING ·Phase: PHASE2
-
The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty
NCT02504125 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
NCT01882374 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison of Topical Versus Intravenous Tranexamic Acid in TKA
NCT02393300 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Using Tranexamic Acid by Different Means to Reduce Blood Loss During Total Knee Replacement
NCT02117128 ·Status: COMPLETED ·Phase: PHASE4
-
Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass
NCT02122679 ·Status: WITHDRAWN ·Phase: PHASE4
-
Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery
NCT03101124 ·Status: COMPLETED ·Phase: PHASE2
-
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
NCT06345833 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Tranexamic Acid in Pediatric Cardiac Surgery
NCT00994994 ·Status: COMPLETED ·Phase: NA
-
Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
NCT01031992 ·Status: COMPLETED ·Phase: PHASE3
-
Laser Photocoagulation in Twin to Twin Transfusion Syndrome
NCT02506049 ·Status: COMPLETED ·Phase: NA
-
The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty
NCT03074994 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravenous Tranexamic Acid During Rhytidectomy
NCT03970213 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement
NCT01850394 ·Status: COMPLETED ·Phase: NA
-
Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection
NCT01651182 ·Status: COMPLETED ·Phase: PHASE3
-
Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure
NCT04410042 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA
NCT02922582 ·Status: TERMINATED ·Phase: PHASE2
-
Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
NCT00657384 ·Status: TERMINATED ·Phase: PHASE3
-
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
NCT03365999 ·Status: COMPLETED ·Phase: PHASE2
-
TXA vs. Amicar in Total Knee and Hip Arthroplasty
NCT02030821 ·Status: COMPLETED ·Phase: PHASE4
-
Fibrinogen Early In Severe Trauma studY Junior
NCT03508141 ·Status: UNKNOWN ·Phase: PHASE2
-
Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery
NCT01519245 ·Status: COMPLETED ·Phase: PHASE3
-
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
NCT04531592 ·Status: WITHDRAWN ·Phase: PHASE2